focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

China's Cross-Border Funding Reforms

27 Jun 2014 07:00

RNS Number : 6927K
Adamas Finance Asia Limited
27 June 2014
 



ADAMAS FINANCE ASIA LIMITED

("ADAM" or the "Company)

 

China's cross-border funding reforms

 

 

The Directors of ADAM are pleased to note the newly-introduced reforms designed to ease controls on cross-border lending to Chinese businesses.

 

The new cross-border lending reforms have been introduced during June by China's State Administration of Foreign Exchange ("SAFE") to address concerns that tight credit and slowing investment may stall the country's 7.5% GDP growth objective for 2015. The scale of demand is clear from May figures showing a 12% increase in bank lending to RMB 870.8 billion (approx US$140 billion) following a decision by the central People's Bank of China to cut the reserve requirement ratio on lending banks.

 

According to the law firm Clifford Chance, the new easing of cross-border lending controls can be expected to reduce transaction times and the associated costs for offshore investors who also stand to benefit from increased flexibility and strengthened enforcement over security.

 

ADAM Chairman John Croft said: "We have little doubt the streamlining of rules resulting from the new changes will result in wider investment opportunities within China. Key among the changes is the removal both of quotas and of the need for SAFE approval on security to underpin cross-border lending."

 

Mr. Croft added: "Adamas Asset Management, the Company's investment manager, has demonstrated strong expertise and delivery in achieving high-yield returns from providing growth capital for operationally-sound Chinese businesses. These new moves, and the evidence of huge underlying demand for capital, demonstrate that while adjustments in the Chinese economy will continue to pose challenges for the government, demand from a large number of individual businesses is set to remain strong."

 

 

Enquiries:

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

Nominated Adviser and Broker

W H Ireland Limited

Tim Feather

+44 (0) 113 394 6611

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADQLFLZQFXBBF
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.